Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Pain Manag Nurs ; 25(4): 402-408, 2024 Aug.
Article in English | MEDLINE | ID: mdl-38609805

ABSTRACT

OBJECTIVE: To assess the effect of a teach-back educational intervention using Behavior Change Wheel (BCW) framework on perioperative pain among patients with lung cancer. METHODS: A prospective quasi-experimental study was conducted in 88 patients with lung cancer from a tertiary hospital in China. According to the order of admission, they were allocated to either control group or intervention group, with 44 patients in each group. Patients in the control group received routine nursing care, while patients in the intervention group were given a teach-back education program based on BCW framework. The visual analog scale (VAS) was adopted to evaluate patients' pain on the day of surgery (T0), 1 (T1), 2 (T2), and 3 (T3) days after surgery. We also recorded the use of patient-controlled analgesia (PCA), the length of hospital stay, and the degree of patients' satisfaction. RESULTS: Rest pain, pain when coughing, and pain during activity that patients in the intervention group experienced were significantly less severe than those in the control group on T0 and T1. The pain when coughing in the intervention group was also significantly milder on T2 and T3. In addition, the number of self-control time, use duration, and total dose of PCA were significantly lower in the intervention group. Moreover, patients' satisfaction of nursing service was significantly higher in the intervention group. CONCLUSION: A teach-back education program based on BCW framework was effective in pain management among the perioperative patients with lung cancer. This study demonstrates the application of teach-back method and the BCW in the development of patient education intervention to mitigate perioperative pain.


Subject(s)
Lung Neoplasms , Pain Management , Pain Measurement , Humans , Female , Male , Lung Neoplasms/complications , Lung Neoplasms/surgery , Middle Aged , Prospective Studies , Aged , China , Pain Measurement/methods , Pain Management/methods , Pain Management/standards , Pain Management/statistics & numerical data , Patient Education as Topic/methods , Patient Education as Topic/standards , Patient Education as Topic/statistics & numerical data , Pain, Postoperative/therapy , Adult
2.
Chem Biodivers ; 18(8): e2100231, 2021 Aug.
Article in English | MEDLINE | ID: mdl-34087032

ABSTRACT

Meyeniines A-C (1-3), three new lignans, two known neolignans (4-5), and three known lignans (6-8) were isolated from the rhizomes of Lepidium meyenii. Their structures were identified by comprehensive spectroscopic analyses and computational methods. Compound 1 represents a unique lignan featuring an aromatic ring migration. Compounds 2 and 4-6 were analyzed by chiral HPLC column as enantiomers. Biological evaluation revealed that compound 8 could inhibit IL-6 production in lipopolysaccharide (LPS) induced RAW264.7 cells in a dose-dependent manner.


Subject(s)
Anti-Inflammatory Agents/chemistry , Lepidium/metabolism , Lignans/chemistry , Animals , Anti-Inflammatory Agents/isolation & purification , Anti-Inflammatory Agents/pharmacology , Cell Survival/drug effects , Interleukin-6/metabolism , Lignans/isolation & purification , Lignans/pharmacology , Lipopolysaccharides/pharmacology , Macrophages/cytology , Macrophages/drug effects , Macrophages/metabolism , Magnetic Resonance Spectroscopy , Mice , Molecular Conformation , Plant Extracts/chemistry , RAW 264.7 Cells
SELECTION OF CITATIONS
SEARCH DETAIL